CSF1R and hematopoietic and lymphoid cell neoplasm: In contrast, CSF1R mutations accumulate in the negative regulatory motifs (a c-Cbl ubiquitin ligase binding motif) in the receptor tail, leading to the overactivation of the receptor [65] in various haematopoietic cancers.